Senseonics Holdings (SENS) Reports In-Line Q1 EPS; Reiterates Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Senseonics Holdings (SENS) Reports In-Line Q1 EPS; Reiterates Outlook

Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results

May 10, 2022 4:05 PM EDT

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2022.

Recent Highlights & Accomplishments:

Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System (E3), offering industry leading 6-month sensor wear duration, the longest lasting CGM system available Transitioned manufacturing to E3 to enable U.S. commercial launch through our... More